Evidence map›Paper›PMID 41255622›Full record

ArticleFrontiers in medicine2025

A case report of pulmonary adenocarcinoma with thoracic duct lymphangioma and chylothorax.

Zichun Tang, Rui Xu, Peng Dai, Juncheng Chen, Zongwei Xiao

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zichun Tang *Department of Cardio-Thoracic Surgery, North Sichuan Medical College, Nanchong, Sichuan, China.
Rui Xu *Department of Cardio-Thoracic Surgery, North Sichuan Medical College, Nanchong, Sichuan, China.
Peng DaiDepartment of Cardio-Thoracic Surgery, North Sichuan Medical College, Nanchong, Sichuan, China.
Juncheng ChenDepartment of Neurosurgery, North Sichuan Medical College, Nanchong, Sichuan, China.
Zongwei XiaoDepartment of Cardio-Thoracic Surgery, Chengdu Second People's Hospital, Chengdu, Sichuan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thoracic duct lymphangioma, a rare benign lesion, requires surgical resection. The thoracic duct is highly susceptible to damage during surgery, leading to chylothorax. Therefore, meticulous exploration and gradual dissection are crucial to minimizing this risk. Thoracic duct lymphangioma coexisting with lung adenocarcinoma is clinically rare. Preoperative imaging evaluation should be comprehensive, intraoperative meticulous dissection is crucial to reduce the likelihood of thoracic duct injury, and early intervention for postoperative chylothorax is essential to improve prognosis. This case aims to investigate the clinical characteristics, diagnostic and therapeutic strategies, and prognosis of lung adenocarcinoma complicated with thoracic duct lymphangioma and chylothorax. This case report aims to provide clinical reference for managing such complex cases.

Indexed as

chylothoraxductus thoracicuslung adenocarcinomalymphangiomamediastinal tumor

Identifiers

PMID41255622
PMCPMC12620216

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.